Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €32.22 EUR
Change Today +0.311 / 0.97%
Volume 0.0
3M4 On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 2:08 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

masimo corp (3M4) Snapshot

Open
€32.22
Previous Close
€31.90
Day High
€32.22
Day Low
€32.22
52 Week High
04/14/15 - €32.74
52 Week Low
09/24/14 - €15.94
Market Cap
1.7B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
52.6M
EX-Date
11/23/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MASIMO CORP (3M4)

masimo corp (3M4) Related Businessweek News

No Related Businessweek News Found

masimo corp (3M4) Details

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. It offers Masimo Signal Extraction Technology (SET) with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. The company also provides Masimo rainbow SET Platform, which includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor multiple blood-based measurements, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from pleth; noninvasively monitor hemoglobin, carboxyhemoglobin, and methemoglobin; monitor arterial oxygen saturation; and calculates oxygen content and oxygen reserve index. In addition, it offers SedLine brain function monitoring technology that measures the brain’s electrical activity by detecting EEG signals; capnography and gas monitoring products, such as external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; O3 regional oximetry for tissue oxygen saturation measurement; SafetyNet, a patient surveillance, remote monitoring, and clinician notification solution; and Halo Index, an indicator that facilitates trending and assessment of physiological measurements. Further, the company offers remote alarm/monitoring solutions, software, and connectivity solutions. The company’s patient monitoring technologies incorporate a monitor or circuit board and sensors, including proprietary single-patient use, reusable and rainbow ReSposable sensors, and patient cables. Masimo Corporation provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. The company was founded in 1989 and is headquartered in Irvine, California.

1,200 Employees
Last Reported Date: 02/17/15
Founded in 1989

masimo corp (3M4) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: $830.8K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $346.1K
Chief Operating Officer
Total Annual Compensation: $307.8K
President of Worldwide Oem Business & Blood M...
Total Annual Compensation: $347.4K
President of Worldwide Sales, Professional Se...
Total Annual Compensation: $332.4K
Compensation as of Fiscal Year 2014.

masimo corp (3M4) Key Developments

Masimo Corporation Reports Unaudited Consolidated Earnings Results for the First Quarter Ended April 4, 2015; Provides Earnings Guidance for the Full Year of 2015

Masimo Corporation reported unaudited consolidated earnings results for the first quarter ended April 4, 2015. For the quarter, total revenue was $154,537,000 against $139,814,000 a year ago. Operating income was $27,377,000 against $30,193,000 a year ago. Income before provision for income taxes was $27,530,000 against $30,393,000 a year ago. Net income attributable to the company stockholders was $20,523,000 against $22,632,000 a year ago. Diluted net income per share attributable to the company stockholders was $0.38 against $0.39 a year ago. Net cash provided by operating activities was $19,124,000 against $24,226,000 a year ago. Purchases of property and equipment were $17,218,000 against $3,045,000 a year ago. Increase in intangible assets was $679,000 against $886,000 a year ago. Non-GAAP total revenue was $158,773,000 against $139,814,000 a year ago. Non-GAAP operating income was $29,354,000 against $22,571,000 a year ago. Non-GAAP income before provision for income taxes was $29,073,000 against $22,771,000 a year ago. Non-GAAP net income attributable to the company stockholders was $22,171,000 against $17,902,000 a year ago. Non-GAAP net income per share attributable to the company stockholders was $0.41 against $0.31 a year ago. The company is updating its 2015 financial guidance. The company now expects fiscal 2015 total revenues to be $608 million, up from $605 million and total product revenues to be $580 million, up from $577 million. The company now also expects its GAAP earnings per diluted share to be $1.33, up from $1.30 and expects non-GAAP earnings per diluted share to be approximately $1.48. The company is projecting fiscal 2015 EBITDA to be approximately $115 million to $120 million.

Masimo Corporation, Annual General Meeting, Jun 02, 2015

Masimo Corporation, Annual General Meeting, Jun 02, 2015., at 14:00 Pacific Standard Time. Location: 40 Parker. Agenda: To elect the following nominee as a Class II director to serve until 2018 annual meeting of stockholders: Mr. Joe Kiani; to elect the following nominee as a Class II director to serve until 2018 annual meeting of stockholders: Mr. Joe Kiani; to vote on an advisory resolution to approve named executive officer compensation; and to conduct any other business properly brought before the annual meeting and any adjournment or postponement thereof.

Masimo Corporation to Report Q1, 2015 Results on May 06, 2015

Masimo Corporation announced that they will report Q1, 2015 results After-Market on May 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3M4:GR €32.22 EUR +0.311

3M4 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $55.70 USD +0.16
Cyberonics Inc $65.40 USD +1.39
ICU Medical Inc $98.36 USD +1.36
NuVasive Inc $49.85 USD -0.70
Thoratec Corp $45.75 USD +0.36
View Industry Companies
 

Industry Analysis

3M4

Industry Average

Valuation 3M4 Industry Range
Price/Earnings 27.2x
Price/Sales 3.1x
Price/Book 5.7x
Price/Cash Flow 26.1x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MASIMO CORP, please visit www.masimo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.